Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Biofluid Biopsies
Conferences  \  Biofluid Biopsies and Companion Diagnostics 2014  \  Biofluid Biopsies  \  Agenda  \  Martin Siaw
RegisterLogin

Martin Siaw's Biography


Martin Siaw, Associate Scientific Director, Quest Diagnostics Nichols Institute

Martin Siaw is currently the Associate Director of Advanced Sequencing at Quest Diagnostics. He has many years of laboratory experience and technical expertise in assay development for the biotechnology and medical diagnostics industry. He was the technical co-lead for the development of the first NGS based test for HIV-1 Tropism that is being offered by Quest. Currently, he is focused on advancing the use of next generation sequencing technologies for molecular diagnostic testing geared towards improving patient care in Infectious Diseases, Genetics, Oncology and various other clinical sub-specialties.

Martin Siaw Image

Next Generation Sequencing for Clinical Applications: Challenges in Developing Clinical Tests

Monday, 27 October 2014 at 09:45

Add to Calendar ▼2014-10-27 09:45:002014-10-27 10:45:00Europe/LondonNext Generation Sequencing for Clinical Applications: Challenges in Developing Clinical TestsSELECTBIOenquiries@selectbiosciences.com

Next Generation Sequencing has evolved very rapidly and is now used for molecular testing in clinical laboratories This powerful technology offers many exciting opportunities for use in clinical testing.  However, NGS also presents many challenges as well.  These challenges include the differences between research and clinical labs, and the rapid evolution of platforms, protocols, and reagents.  There is a need to recognize the NGS challenges that are specific to CLIA lab environments and to identify some of the considerations that are needed when developing and validating clinical NGS tests.  Some specific clinical applications will be presented.

Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonBiofluid BiopsiesSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors